TableĀ 3

MitraClip Device Complications

EVEREST High-Risk Cohort
(NĀ = 351)
Early Phase
(Through 30 Days)
Late Phase
(>30 Days)
Single leaflet device attachment rate1.7 (6/351)0.6 (2/351)
Mitral valve surgery0.3 (1/351)0.6 (2/351)
Second MitraClip procedure1.1 (4/351)0.0 (0/351)
MitraClip embolization0.0 (0/351)0.0 (0/351)
Mitral valve stenosis0.0 (0/351)0.9 (3/351)

Values are % (n/N).